Laura Svetkey
Overview
Explore the profile of Laura Svetkey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
533
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miller H, Miller H, Askew S, Berger M, Kay M, Palipana A, et al.
Hypertension
. 2024 Dec;
82(2):370-381.
PMID: 39711367
Background: Dietary Approaches to Stop Hypertension (DASH) is a recommended first-line treatment for adults with hypertension, yet adherence to DASH is low. To evaluate the efficacy of a digital health...
2.
Miller H, Askew S, Berger M, Trefney E, Blackman Carr L, Kay M, et al.
Digit Health
. 2024 Oct;
10:20552076241281216.
PMID: 39360240
Introduction: Clinical trials often enroll nonrepresentative participant samples, limiting generalizability of trial findings. The current analysis explores the influences of remote recruitment and screening protocols on participation in a digital...
3.
Miller H, Berger M, Askew S, Trefney E, Tyson C, Svetkey L, et al.
J Cardiovasc Nurs
. 2022 Apr;
37(5):475-481.
PMID: 35467561
Background: The Dietary Approaches to Stop Hypertension eating plan is an evidence-based treatment of hypertension; however, adherence to the Dietary Approaches to Stop Hypertension is low. To improve adherence to...
4.
Underutilization of Guideline-based Abdominal Aortic Aneurysm Screening in an Academic Health System
Anjorin A, Greiner M, Vemulapalli S, Svetkey L, Southerland K, Bosworth H
Ann Vasc Surg
. 2021 Dec;
83:184-194.
PMID: 34942338
Objectives: The US Preventive Services Task Force (USPSTF) recommends a 1 time screening for AAA with ultrasonography in men aged 65-75 who have ever smoked. Our objectives were to identify...
5.
Sata S, Vekstein B, Svetkey L, Criscione-Schreiber L, Cooney K
Acad Med
. 2021 Feb;
96(5):e17-e18.
PMID: 33538481
No abstract available.
6.
Lin P, Grambow S, Intille S, Gallis J, Lazenka T, Bosworth H, et al.
JMIR Mhealth Uhealth
. 2018 Oct;
6(10):e10471.
PMID: 30341051
Background: Understanding how engagement in mobile health (mHealth) weight loss interventions relates to weight change may help develop effective intervention strategies. Objective: This study aims to examine the (1) patterns...
7.
Steinberg D, Bennett G, Svetkey L
JAMA
. 2017 Mar;
317(15):1529-1530.
PMID: 28278326
No abstract available.
8.
Kandzari D, Bhatt D, Brar S, Devireddy C, Esler M, Fahy M, et al.
Eur Heart J
. 2014 Nov;
36(4):219-27.
PMID: 25400162
Aims: The SYMPLICITY HTN-3 randomized, blinded, sham-controlled trial confirmed the safety of renal denervation (RDN), but did not meet its primary efficacy endpoint. Prior RDN studies have demonstrated significant and...
9.
Wingo B, Desmond R, Brantley P, Appel L, Svetkey L, Stevens V, et al.
J Nutr Educ Behav
. 2013 Feb;
45(4):314-21.
PMID: 23433966
Objectives: Determine whether self-efficacy independently predicted weight loss in a behavioral intervention and explore factors that influence the path between self-efficacy and weight change. Design: Secondary analysis of the PREMIER...
10.
Chatterjee R, Thomas L, Svetkey L, Brancati F, Califf R, Edelman D
Am J Hypertens
. 2013 Feb;
26(6):723-6.
PMID: 23417031
Background: Low and low-normal serum potassium is associated with an increased risk of diabetes. We hypothesized that the protective effect of valsartan on diabetes risk could be mediated by its...